Group 1: Company Overview - The company specializes in consumer products, including PCBA (e.g., nebulizer controllers) and finished consumer goods (e.g., small appliances) [2] - The revenue from nebulizer controllers has declined, while income from small appliances and home electronics has increased [2] Group 2: Product and Market Insights - The company is optimistic about the consumer segment for the upcoming year due to new product introductions and gradual mass production [2] - In the robotics sector, the company focuses on pool cleaning robots, collaborating with clients such as UBTECH and StarMaker Innovation [3] Group 3: Storage Business and Competitive Edge - The core market for the company's energy storage products is in Africa, specifically in countries like Nigeria, Kenya, and Tanzania, targeting off-grid household electricity needs [3] - The company's competitive advantage lies in manufacturing processes and strong cost control capabilities [3] Group 4: Challenges and Strategic Responses - The company faces challenges including rising management costs due to factory relocations and new factory construction in Thailand, as well as pressure on average selling prices affecting gross margins [3] - Strategies to address these challenges include enhancing automation, optimizing production layout, and increasing the proportion of high-value-added products [3] Group 5: Future Plans and Financial Strategy - The company is actively seeking investment opportunities that align with its upstream and downstream operations, prioritizing firms with strong technology, brand influence, or established sales channels [3] - The increase in bank credit limit for 2026 is aimed at supporting potential external investments or asset acquisition plans [3] Group 6: Disclosure Information - The activity did not involve any undisclosed significant information [3]

Group 1: Automotive Business Overview - The company focuses on the development, production, and sales of high-strength precision fasteners and special connectors, primarily used in automotive engine turbocharging systems, transmission control systems, exhaust systems, and key components of vehicles [2][3] - In the new energy vehicle sector, products are applied in battery trays, chassis, body, electronic control inverters, and battery swapping systems [3] Group 2: Commercial Aerospace Business Overview - The commercial aerospace sector includes manufacturing rocket structural components, such as body segments, fairings, fuel tanks, and engine valves, with production lines completed in 2024 [3] - The company has established a strong customer base among leading private rocket companies in China [3] Group 3: Competitive Landscape and Capacity Planning - The supply of rocket structural components is a bottleneck in the commercial aerospace sector, with a favorable competitive landscape [3] - The company has a production capacity of 10 rockets per year, with the ability to increase capacity based on order demand, requiring approximately four months for expansion [3] Group 4: Revenue Growth Drivers in Automotive Business - Key drivers for revenue growth include expansion in automotive parts exports, with a focus on overseas markets and strong relationships with major international suppliers [4] - Domestic growth is supported by new customer development, product category expansion, industry consolidation, and localization [4] Group 5: Profitability and Margin Trends - The automotive business has experienced a decline in gross margin due to factors such as a slowdown in industry growth, rising material costs since late 2021, and increased depreciation from new projects [4] - The company anticipates a recovery in profitability as new factory capacities are released, with expectations for improved margins in the future [4] Group 6: Information Disclosure and Communication - The company adheres to strict information disclosure management practices, ensuring transparency and accuracy in communications with investors [5]

Group 1: Company Overview - The company focuses on anti-corrosion and wear-resistant welding equipment, continuously expanding into industrial equipment manufacturing and high-end structural components [1] - Key technologies include material, process, and equipment, with certifications such as the National Special Equipment Production License and ASME certification [1] - The management team has extensive industry experience and a stable core technical staff, enhancing the company's competitive edge [1] Group 2: Market Opportunities - The waste incineration market is expanding, driven by urbanization in developing countries, with countries like Vietnam and Thailand prioritizing waste-to-energy solutions [3][4] - The coal-fired power generation sector shows significant growth potential, with increasing demand for upgrades in developed regions [2] - The company has strategically positioned itself in HRSG and composite pipe businesses, with HRSG already achieving substantial production capacity [2] Group 3: International Expansion - As of September 30, 2025, overseas revenue reached approximately 200 million, accounting for about 54.28% of total revenue, with exports primarily to Asia, the US, South America, and Europe [5] - The company has established a factory in Vietnam, which has commenced operations, and is expanding into the Middle East oil and gas pipeline market [2] Group 4: Competitive Landscape - In the Vietnamese market, competitors include manufacturers from South Korea, Thailand, and Vietnam, but the company holds advantages in production costs and established customer relationships [6][8] - The company plans to expand its HRSG production lines in Vietnam from 4 to a total of 12, depending on market demand [8] Group 5: Pricing and Future Outlook - HRSG pricing is determined by material and labor costs, with adjustments based on market demand and production capacity [9] - The global oil and gas pipeline market is expected to grow due to increasing natural gas demand and the need for infrastructure upgrades, with the company adapting its production strategy to align with market needs [9]

■特定对象调研 □媒体采访 □新闻发布会 □现场参观 □分析师会议 □业绩说明会 □路演活动 ■其他 线上交流 华金证券股份有限公司 2025 年 12 月 5 日 15:00-15:40 线上会议 董事会秘书 吴小霜女士 证券事务代表 谢海桐女士 交流主要内容包括： 董事会秘书、证券事务代表介绍了公司发展历史、公司经营模式及公司主营业 务等情况，并进行交流。 【回复】自上市以来，公司发展依托两条路并行，一边是现有主营业务的发 展。在战略布局上，公司将继续拓展现有包装制品类主营业务的品类和规模。 公司除原有业务外，公司将以市场为导向，以应用于饮料和食品包装领域的 瓶盖业务的研发、生产、销售和相关配套服务为主业，并逐步拓展应用于其 他领域的包装行业的相关产品和业务，包括但不限于应用于日化用品盖、医 疗用品和保健用品瓶盖等领域的包装用品，增加公司主营业务产品的多样化。 另外一边是拟通过探索多种可能性去扩大公司发展规模和业务，实现公司的 外延式增长。 对于公司发展战略的考虑：一方面，公司已于 2021 年并购翔兆科技，通 过上市公司销售团队和研发团队的赋能，新型拉环盖业务获得了一定增长。并 购翔兆科技给公司带来营收 ...

Group 1: Investor Relations Activity - The investor relations activity involved a meeting with analysts from Morgan Fund Management, Guolian Minsheng Securities, and Shenzhen Yide Global Fund Management on December 8, 2025 [1] - The meeting was held in the company conference room and included discussions on the company's new drug inclusion in the national medical insurance directory [1] Group 2: New Drug Inclusion - The innovative drug, Olanavir Tablets (brand name: Anruiwei®), was included in the National Medical Insurance Directory on December 7, 2025, following negotiations with the National Healthcare Security Administration [1][3] - Other core products such as Liraglutide Tablets and various capsules were also included in this directory, enhancing their market accessibility [1] Group 3: Drug Characteristics - Olanavir Tablets are the world's first oral drug targeting the PB2 subunit of the RNA polymerase of the influenza A virus, approved for adult patients with uncomplicated influenza [3][4] - The drug demonstrates rapid symptom relief, strong antiviral effects, and low resistance rates, with positive results from clinical trials [4][5] Group 4: Sales and Marketing Strategy - The company plans to enhance marketing through three dimensions: building an academic ecosystem, upgrading data services, and implementing key project practices [8] - The inclusion of Olanavir Tablets in the National Medical Insurance Directory is expected to positively impact market promotion and long-term business development [8] Group 5: Pediatric Development Plans - The company is developing Olanavir Granules for children and adolescents, with ongoing Phase III clinical trials for both adolescents (ages 12-17) and children (ages 2-11) [9][11] - The trials aim to establish a comprehensive treatment matrix for influenza across all age groups [11] Group 6: Other Drug Developments - RAY1225 injection, an innovative dual-agonist drug for type 2 diabetes and obesity, has shown positive results in Phase II clinical trials and is progressing to Phase III trials [12][13] - ZSP1601 tablets, targeting metabolic dysfunction-related fatty liver disease, have completed early clinical trials with promising results and are moving into Phase IIb trials [15][16] Group 7: Research and Development Pipeline - The company is focusing on innovative drug development in respiratory and metabolic diseases, with projects targeting unmet clinical needs [16][18] - Ongoing research includes a new drug for respiratory syncytial virus (RSV) and various GLP-1 receptor agonists, with clinical candidates identified and preclinical studies underway [16][18]

问 3：请介绍公司未来除了将在手能源指标资产化项目化， 是否还有对外并购规划。 证券代码：002480 证券简称：新筑股份 成都市新筑路桥机械股份有限公司 投资者关系活动记录表 编号：2025-007 投 资 者关 系 活 动类别 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 （请文字说明其他活动内容） 活动参与人员 公司参与人员：董事会秘书陈思遥、首席合规官贾珺； 四川蜀道清洁能源集团有限公司：总工程师孙周； 参与机构：国新控股（四川）有限公司、国新盛康私募基金管 理（北京）有限公司 时间 2025 年 12 月 4 日（星期四）下午 3:00-5:00 地点 蜀道清洁能源集团 240 会议室 形式 现场交流 交 流 内容 及 具 体问答记录 一、基本情况介绍 成都市新筑路桥机械股份有限公司（以下简称"新筑股份 或公司"）副总经理、董事会秘书陈思遥简要介绍了公司历史 沿革、产业现状和本次重组背景，同时介绍了控股股东蜀道集 团三大主业板块（含清洁能源板块）、发展规划和产业协同。 二、问答环节 问 1：新筑股份本次重大资产重组完成后，对公司营收 ...

Group 1: Company Overview and Strategy - Hunan Jiutian Pharmaceutical Co., Ltd. is focusing on expanding its market presence through a multi-channel strategy and brand enhancement initiatives, including the launch of the "Jiutian Zhen Tong Xian Sheng" branding campaign on December 6, 2025 [2][3] - The company aims to strengthen its product pipeline by increasing R&D investments and introducing new products, while also leveraging its integrated supply chain to control costs and ensure product quality [3][4] Group 2: Product Specifics and Market Response - The company’s key product, Loxoprofen Sodium Gel Patch, has been selected in the 11th round of national drug centralized procurement at prices of ¥17.88 for 4 patches, ¥26.82 for 6 patches, and ¥35.76 for 8 patches, with a total planned selection of approximately 30.12 million patches [5] - Following the price reduction from centralized procurement, the company anticipates a potential increase in sales volume for Loxoprofen Sodium Gel Patch, contingent on market conditions post-implementation [5] Group 3: Mergers and Acquisitions - The company has acquired a 67% stake in Hunan Nona Pharmaceutical Technology Co., Ltd., which includes 67 drug licenses, enhancing its product offerings and market stability [3][4] - This acquisition is expected to fill potential sales gaps from the centralized procurement of Loxoprofen Sodium Gel Patch and diversify the product range with unique offerings like the Daiwen Moxibustion Patch [3] Group 4: Innovation and R&D Focus - The company is transitioning towards innovative drug development, establishing multiple R&D centers and focusing on various drug forms and cooperative models to expedite the development of new drugs [4][6] - Current R&D efforts are concentrated on oncology and chronic disease treatments, utilizing small molecules, peptides, and other advanced drug forms to build a robust pipeline [4][6] Group 5: Future Product Development - The JIJ02 gel is expected to complete Phase I clinical trials in the first half of 2026, with plans to initiate Phase II trials thereafter [7] - The company is optimistic about the market prospects for Ketoprofen Gel, which was approved in 2023 and included in the national medical insurance directory, and is implementing new sales strategies to enhance market penetration [7]

Group 1: Company Strategy and Innovation - The company emphasizes technological innovation as the foundation for its growth and industry leadership, addressing consumer pain points with solutions like the "blade battery" for safety and "DM-i super hybrid" for economic efficiency [2] - The R&D team, consisting of 120,000 members, is focused on developing advanced technologies to lead the industry in the coming years [2] - The company is committed to enhancing its design and marketing efforts to improve brand perception and consumer engagement [2] Group 2: Market Competition and Adaptation - The company acknowledges the intense market competition and is actively learning from successful practices of new entrants in the electric vehicle sector [2] - It plans to launch impressive technologies across its main and high-end brands, aiming to strengthen its market position and enhance global brand reputation [2] Group 3: Technology Communication and Marketing - The company has introduced technologies like "Heavenly Eye" and "Megawatt Flash Charge" to solidify its technological moat and intends to play a leading role in the industry [4] - The focus is on long-term growth through technology rather than aggressive short-term marketing tactics, ensuring sustainable market presence [4] Group 4: Artificial Intelligence and User Engagement - The company is heavily investing in artificial intelligence across various aspects, recognizing its transformative potential in the automotive industry [4] - With approximately 15 million electric vehicle users, the company prioritizes user feedback to guide its R&D efforts and enhance consumer experience [4] Group 5: Investor Relations - As of the end of Q3, the company has 640,000 shareholders and aims to maintain transparent communication while being cautious about revealing strategic plans in a competitive environment [4] - The company expresses gratitude towards its shareholders and is committed to delivering sustainable and innovative products for long-term benefits [5]

Company Overview - Yinchuan Weili Transmission Technology Co., Ltd. has a core production base located in Yinchuan, with all production capacity deployed there. The company focuses on precision reducers, wind power gearboxes, and electric drive-related capacities [1][2]. Industry Barriers - The wind power gearbox industry has high entry barriers, including: - **Technical Barriers**: Complex design requirements and high precision in processing and assembly, necessitating rigorous testing [1][2]. - **Financial Barriers**: Capital-intensive nature requiring significant investment in equipment and R&D [1][2]. - **Customer and Certification Barriers**: Strict supplier admission criteria and lengthy validation periods of 2-3 years [1][2]. - **Brand and Talent Barriers**: New brands struggle to gain trust, and the industry requires multidisciplinary talent [1][2]. Production Capacity - The first phase of the wind power gearbox smart factory is expected to achieve an annual production capacity of 2,000 units, with plans to increase to 4,000 units after the second phase [2][3]. Project Progress - The smart factory project is progressing steadily, with core production equipment deployed and ongoing adjustments to ensure operational stability. The company is actively recruiting and training staff for key positions [3][4]. Capacity Ramp-Up - The wind power gearbox smart factory is currently in the initial ramp-up phase, facing challenges such as: - Need for improved operational proficiency among the production team [3]. - Continuous optimization of production line processes [3]. - Ongoing equipment debugging and performance calibration [3]. Profitability Expectations - The smart factory is expected to significantly enhance the gross margin of the wind power gearbox business due to increased product value and cost reductions from economies of scale. The gross margin is anticipated to exceed that of conventional wind power gearbox products [4].

证券代码：002063 证券简称：远光软件 3.大数据业务未来的发展怎么看？ 公司不断推进大数据业务深化，当前聚焦数据治理、数 据场景服务、工具提供及智能场景，未来潜力在于激活客户 数据要素价值。电网数据真实、全面，能反映经济运行情况， 可用于多种场景。公司正积极探索与客户更多的合作模式， 未来将数据作为生产要素赋能更多领域，构建新增长极。 4.公司是否设有投资部，会并购与业务相关的标的吗？ 公司设有产业投资部，除了对子公司进行投后管理，提 供资源支持及业务赋能，负责低质无效资产的清理与处置， 如有合适标的，公司不排除通过并购重组方式扩大营收。 5.公司是否会考虑通过回购股份或分红等方式提升市 值？ 公司会综合考虑多种因素来决定是否采取回购股份、分 红、增持、股权激励或投资并购等措施提升市值。具体决策 将取决于公司资金的使用安排、股价表现以及回购用途等， 目前对各类提升市值的方式均持开放态度，但具体实施时点 需视实际情况评估确定。 远光软件股份有限公司 投资者关系活动记录表 编号： 20250024 投资者关系活动 类别 特定对象调研 □分析师会议 □媒体采访 业绩说明会 □新闻发布会 □路演活动 □现场参观 ...